Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Negative Breast Cancer Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05115474
What this trial is testing

Study of Screening Brain MRIs in Stage IV Breast Cancer

Who this might be right for
Triple Negative Breast CancerHER2-positive Breast CancerHormone Receptor-positive Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 170
Testing effectiveness (Phase 2)Ended earlyNCT03801369
What this trial is testing

AMTEC IIT: Phase 2 Multiarm Study in TNBC

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast Carcinoma
Gordon Mills, MD, PhD 24
Testing effectiveness (Phase 2)Ended earlyNCT01194869
What this trial is testing

Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Emory University 25
Testing effectiveness (Phase 2)Study completedNCT02404441
What this trial is testing

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Sell Lung Cancer (NSCLC)Triple Negative Breast Cancer+2 more
Novartis Pharmaceuticals 319
Early research (Phase 1)Study completedNCT04580485
What this trial is testing

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

Who this might be right for
Ovarian CancerBladder CancerNon Small Cell Lung Cancer+8 more
Incyte Corporation 54
Early research (Phase 1)Study completedNCT01520389
What this trial is testing

Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Who this might be right for
Advanced Solid TumorsColorectal CancerSquamous Cell Head and Neck Cancer+2 more
Merrimack Pharmaceuticals 112
Not applicableLooking for participantsNCT06422455
What this trial is testing

Access to Genetic Testing in Underserved Patients With Cancer

Who this might be right for
Breast CarcinomaMale Breast CarcinomaMalignant Solid Neoplasm+5 more
University of Southern California 800
Testing effectiveness (Phase 2)Active Not RecruitingNCT04176848
What this trial is testing

CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Canadian Cancer Trials Group 15
Testing effectiveness (Phase 2)WithdrawnNCT05008510
What this trial is testing

P2 Clinical Efficacy & Safety Study of V-111 Monotherapy & Sacituzumab Govitecan-hziy/V-111 Combo Therapy for mTNBC .

Who this might be right for
Metastatic Triple Negative Breast Cancer
Veru Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06224673
What this trial is testing

ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer

Who this might be right for
HER2 Low Breast CarcinomaTriple Negative Breast CancerHormone-receptor-positive Breast Cancer+1 more
Laura Huppert, MD, BA 36
Not applicableLooking for participantsNCT06931769
What this trial is testing

TAO-Towards Optimal (Neo)Adjuvant Systemic Therapy of Stage III Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 100
Early research (Phase 1)Looking for participantsNCT07623369
What this trial is testing

A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Huahui Health 299
Testing effectiveness (Phase 2)Study completedNCT01653561
What this trial is testing

Apatinib in Non-triple-negative Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Fudan University 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07299409
What this trial is testing

First-Line Sacituzumab Govitecan in Advanced Untreated Triple-Negative Breast Cancer Patients.

Who this might be right for
Advanced Triple Negative Breast CancerBreast Cancer MetastaticBreast Cancer
Nathalie Levasseur 24
Testing effectiveness (Phase 2)Looking for participantsNCT04230109
What this trial is testing

Sacituzumab Govitecan In TNBC

Who this might be right for
Invasive Breast CancerTriple Negative Breast CancerER-Negative Breast Cancer+2 more
Massachusetts General Hospital 239
Large-scale testing (Phase 3)Active Not RecruitingNCT03168880
What this trial is testing

Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Tata Memorial Hospital 720
Testing effectiveness (Phase 2)Study completedNCT05340413
What this trial is testing

Predicting Olaparib Sensitivity in Patients With Unresectable Locally Advanced/Metastatic HER2-negative Breast Cancer.

Who this might be right for
HER2-negative Breast CancerMetastatic Breast CancerTriple Negative Breast Cancer
SOLTI Breast Cancer Research Group 65
Not applicableLooking for participantsNCT06273800
What this trial is testing

Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 100
Testing effectiveness (Phase 2)Ended earlyNCT02003092
What this trial is testing

RX-5902 Treatment of Subjects With Triple Negative Breast Cancer

Who this might be right for
Solid TumorTriple Negative Breast Cancer
Rexahn Pharmaceuticals, Inc. 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07413601
What this trial is testing

Phase 2 Clinical Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Platinum Chemotherapy Versus Platinum Chemotherapy in the Treatment of Second-/Third-line Triple Negative Breast Cancer (TNBC)

Who this might be right for
Triple Negative Breast Cancer Metastatic
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 78
Next Page